You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 10, October 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Motor Neuron Disease With Parkinsonism

Adnan I. Qureshi, MD; George Wilmot, MD, PhD; Bhupesh Dihenia, MD; Julie A. Schneider, MD; David A. Krendel, MD

Arch Neurol. 1996;53(10):987-991.


Abstract

Objective
To report clinical characteristics of patients with combined features of parkinsonism and motor neuron disease (MND).

Design
Medical chart review.

Setting
University medical center.

Patients
Thirteen patients, identified by computer-assisted search, who had diagnoses of both parkinsonism and MND.

Results
Median age was 68 years. There were 7 men and 6 women. All had clinical and electrodiagnostic evidence of both upper and lower motor neuron degeneration. One or more clinical manifestations of parkinsonism were observed in all patients either before the diagnosis of MND (n=2), at the time of initial evaluadon (n=10), or after the diagnosis of MND (n=1). The median time from symptom onset to presentation was 18 months. Improvement was seen in 5 of the 11 patients treated with levodopa. Dementia and autonomic dysfunction were absent in all patients. Postmortem neuropathological evaluation, available in 1 patient, demonstrated degeneration of the substantia nigra with Lewy bodies, mild pallor of the medullary pyramids, and neurogenic atrophy of the skeletal muscle.

Conclusion
The onset of MND and parkinsonism within a relatively short period in most of our patients favors a common pathogenic mechanism over coincidental occurrence of 2 unrelated diseases. In patients with MND, it is important to recognize signs of parkinsonism that levodopa might alleviate.



Author Affiliations

From the Departments of Neurology (Drs Qureshi, Wilmot, Dihenia, Schneider, and Krendel) and Pathology (Dr Schneider), Emory University School of Medicine, Atlanta, Ga.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement
Mabuchi et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1768-1771.
ABSTRACT | FULL TEXT  

Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy
Paviour et al.
Brain 2004;127:2441-2451.
ABSTRACT | FULL TEXT  

Amyotrophic Lateral Sclerosis
Rowland and Shneider
NEJM 2001;344:1688-1700.
FULL TEXT  

Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature
Mathuranath et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:304-312.
ABSTRACT | FULL TEXT  

Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion
Desai and Swash
J. Neurol. Neurosurg. Psychiatry 1999;67:214-216.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.